Royalty Pharma increases quarterly dividend 5% to 22c per share

Royalty Pharma (RPRX) announced that its board of directors has declared a dividend for the first quarter of 2025 of 22c per Class A ordinary share, reflecting a 5% increase in the company’s quarterly dividend over the previous quarter’s dividend. The dividend will be paid on March 10 to shareholders of record at the close of business on February 21.